Innovexia Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 17-11-2024
- Paid Up Capital ₹ 5.00 M
as on 17-11-2024
- Company Age 13 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.18 Cr
as on 17-11-2024
About Innovexia Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company has closed loans amounting to ₹1.18 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Reecha Sharma, Rohit Sharma, and Sandeep Khajuria serve as directors at the Company.
- CIN/LLPIN
U24100CH2011PTC033197
- Company No.
033197
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Aug 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Innovexia Life Sciences Private Limited offer?
Innovexia Life Sciences Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antifungal Cream, Ointment & Powder, Cardiovascular Drugs & Medication, Diabetes Medicine, Nutraceuticals & Dietary Supplements, Nutritional Supplements, Blood Pressure Medicine, Pharma & Bioanalytical Services, PCD Pharma Franchise, Vitamin Tablets & Capsules.
Who are the key members and board of directors at Innovexia Life Sciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sandeep Khajuria  | Director | 31-Jul-2020 | Current |
| Reecha Sharma | Director | 25-Aug-2011 | Current |
| Rohit Sharma | Director | Current |
Financial Performance of Innovexia Life Sciences.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Innovexia Life Sciences?
Unlock access to Innovexia Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
₹0
₹11.75 M
Charges Breakdown by Lending Institutions
- Others : 1.18 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Feb 2018 | Others | ₹1.03 Cr | Satisfied |
| 18 Sep 2012 | Others | ₹1.45 M | Satisfied |
How Many Employees Work at Innovexia Life Sciences?
Unlock and access historical data on people associated with Innovexia Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Innovexia Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Innovexia Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.